Willow Neuroscience
Biotechnology Research • 
San Carlos, California, United States • 1-10 Employees
Company overview
| Headquarters | 930 Brittan Ave, San Carlos, California 94070, US |
| Website | |
| NAICS | 541714 |
| Founded | 2016 |
| Employees | 1-10 |
Key Contact at Willow Neuroscience
Ben Williams
CEO & Director
Willow Neuroscience Email Formats
Willow Neuroscience uses 1 email format. The most common is {last name} (e.g., doe@mit.edu), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{last name} | doe@mit.edu | 100% |
About Willow Neuroscience
Willow Biosciences is a Stanford-founded company reversing aging at its source. Our lead programs are an IDO1 inhibitor for early Alzheimer’s — near human trials and shown in preclinical models to reverse dementia-like symptoms by restoring brain energy supply — and TREM1-PET, a first-in-class companion diagnostic already in clinical trials to track both TREM1 and EP2 activation. TREM1-PET guides patient selection and treatment monitoring to increase trial success rates and will directly inform the highest-value disease indications for our pipeline. Next in line are our EP2 and TREM1 antibody programs, designed for systemic rejuvenation and high-inflammation conditions. EP2 blockade has already demonstrated 11 of 12 hallmarks of aging in preclinical studies, with the potential for the human equivalent of two decades of biological age reversal — compared to ~3 years for GLP-1 drugs like Ozempic®. With full ownership of our companion diagnostic IP, we control both the therapeutic and the patient selection tool, creating a Keytruda-style model with a stronger moat. We are raising $8M to take the IDO1 inhibitor through IND-enabling studies and start Phase 1 trials for TREM1-PET, while advancing EP2 and TREM1 antibodies toward the clinic — targeting human proof-of-concept for both a therapeutic and a diagnostic by 2028.
Willow Neuroscience revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Willow Neuroscience has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Willow Neuroscience has never raised funding before.
Denmark
United Kingdom
Netherlands
Spain
FranceFrequently asked questions
4.8
40,000 users
